|
Volumn 28, Issue 7, 2006, Pages 542-544
|
Effectiveness and safety of recombinant human interleukin-11 in the treatment of chemotherapy-induced thrombocytopenia
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
INTERLEUKIN 11;
PACLITAXEL;
RECOMBINANT PROTEIN;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
FATIGUE;
FEMALE;
GENETICS;
HUMAN;
LUNG TUMOR;
MALE;
MIDDLE AGED;
STOMACH TUMOR;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CARBOPLATIN;
FATIGUE;
FEMALE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
INTERLEUKIN-11;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
PACLITAXEL;
PLATELET COUNT;
RECOMBINANT PROTEINS;
STOMACH NEOPLASMS;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
|
EID: 39149138145
PISSN: 02533766
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (9)
|
References (0)
|